National Cancer Institute cohort
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (9)
Papers in which this entity is mentioned.
- Efficient and accurate search in petabase-scale sequence repositories. (2025)
- A Novel Tissue-Free Method to Estimate Tumor-Derived Cell-Free DNA Quantity Using Tumor Methylation Patterns. (2023)
- Inferring gene expression from cell-free DNA fragmentation profiles. (2022)
- Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA. (2021)
- Application of third-generation sequencing in cancer research. (2021)
- Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project. (2020)
- Predicting T cell recognition of MHC class I restricted neoepitopes. (2018)
- Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing. (2015)
- Detectable clonal mosaicism from birth to old age and its relationship to cancer. (2012)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| national cancer institute | cohort | 13 | 16 |
| nci | cohort | 4 | 6 |